About Us
Our understanding of human physiology and disease susceptibility is dramatically changing. We now recognize that our bodies integrate the biology of our human cells and genome with the trillions of bacteria that live within and on us. In fact, a significant component of disease is derived from these microbial communities. Defining the processes and events responding to our microbiota offers new insights into disease processes, defines new relationships governing the natural history of human disease, and offers new approaches to treat and prevent disease
More About Us
Research News
Machine learning crunches the numbers to more easily spot drug targets for diseases influenced by the gut microbiome.
Dr. Hazen identified the gbu gene cluster as a potential therapeutic target for diet-associated cardiovascular disease, and showed that dietary modifications may also help reduce risk.
Dr. Sharifi and collaborators identified choline, betaine and phenylacetylglutamine as nutrients and gut microbiome metabolites associated with increased risk for lethal prostate cancer, suggesting dietary interventions may help reduce disease risk.